These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13985873)

  • 1. [Clinical trials of a new hypotensive drug: 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate].
    POZZI LL; CAGNONI M
    Gazz Med Ital; 1963 Jan; 122():1-7. PubMed ID: 13985873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the hypotensive effect of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (mebutamate)].
    MARANGONI R; MELLONI GF
    Atti Soc Ital Cardiol; 1962 Jun 1-3; 2():269-71. PubMed ID: 13932756
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on a new product with hypotensive action (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)].
    BOSISIO P; SCAGLIETTI C
    Minerva Med; 1962 Apr; 53():1101-6. PubMed ID: 13871584
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the hypotensive action of mebutamate (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)].
    MELLONI G; MARANGONI R
    Minerva Med; 1962 Apr; 53():1085-100. PubMed ID: 14472419
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new antihypertensive agent with central action: 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (mebutamate)].
    CUGURRA F
    Clin Ter; 1962 Jun; 22():1046-54. PubMed ID: 13882583
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary observations on a new hypotensive agent: 2-sec-butyl-2-methyl-1,3-propanediol dicarbamate].
    GRANDINETTI P
    Minerva Med; 1962 Apr; 53():1113-4. PubMed ID: 13901099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical research with a new hypotensive agent: 2-sec-butyl-2-methyl-1,3-propanediol dicarbamate (mebutamate)].
    ANNONI G; MAGGI A
    Minerva Med; 1962 Apr; 53():1108-13. PubMed ID: 13861699
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacological properties of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (Mebutamate, W-583), a new centrally acting blood pressure lowering agent.
    BERGER FM; DOUGLAS JF; KLETZKIN M; LUDWIG BJ; MARGOLIN S
    J Pharmacol Exp Ther; 1961 Dec; 134():356-65. PubMed ID: 13867648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action on the circulation of 2-methyl-2-butyl-1,3-propanediol dicarbamate (mebutamate)].
    TACCARDI B; MACCARI M; VALLI A
    Arch Ital Sci Farmacol; 1961 Jul; 11():207-15. PubMed ID: 13918847
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the antihypertensive effectiveness of a new propanediol dicarbamate (W-583).
    DUARTE C; BREST AN; KODAMA R; NASO F; MOYER JH
    Curr Ther Res Clin Exp; 1960 May; 2():148-52. PubMed ID: 13818273
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).
    SELLING LS
    J Am Med Assoc; 1955 Apr; 157(18):1594-6. PubMed ID: 14367012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Personal experience with 2-methyl-2-propyl-1, 3-propanediol dicarbamate in a group of allergic patients].
    GARAT B; BERRUEZO JJ; ORCIUELI L
    Dia Med; 1957 Mar; 29(10):234; passim. PubMed ID: 13427602
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.
    BORRUS JC
    J Am Med Assoc; 1955 Apr; 157(18):1596-8. PubMed ID: 14367013
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the absorption of acetylsalicylic acid and salicylates in association with N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (Carisoprodol)].
    CARPI C; PARENTI MA; MANDELLI V
    Farmaco Prat; 1963 Apr; 18():199-205. PubMed ID: 14040581
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system.
    HENDLEY CD; LYNES TE; BERGER FM
    Proc Soc Exp Biol Med; 1954 Dec; 87(3):608-10. PubMed ID: 13237321
    [No Abstract]   [Full Text] [Related]  

  • 16. Soma: normal hematopoletic response to hematinics during the administration of N-isopropyl-2-methyl-2-propyl-1, 3-propanediol dicarbamate.
    BARNARD RD; BILLOW BW
    Harlem Hosp Bull (N Y); 1960 Mar; 1():68-71. PubMed ID: 13796855
    [No Abstract]   [Full Text] [Related]  

  • 17. [REMOTE CLINICAL EVALUATION OF THE HYPOTENSIVE ACTION OF 2-METHYL-2-SEC-BUTYL-1-3-PROPANDIOL BICARBAMATE (MEBUTAMATE)].
    TUDINI F
    Gazz Med Ital; 1963 Nov; 122():345-51. PubMed ID: 14117175
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of arterial hypertension with 2-methyl-2-sec-butyl-1, 3-propanediol dicarbamate (mebutamate)].
    BUONINCONTI R
    Gazz Med Ital; 1963 Feb; 122():54-6. PubMed ID: 14016864
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.
    BERGER FM
    J Pharmacol Exp Ther; 1954 Dec; 112(4):413-23. PubMed ID: 13222235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological properties of a new synthetic derivative with central depressive activity: 2,2-bis(chloromethyl)-1,3-propanediol (dispranol)].
    DELLA BELLA D; ROGNONI F
    Boll Chim Farm; 1960 Feb; 99():67-78. PubMed ID: 13815673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.